Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 6OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2

Conditions

Neoplasms, Basal Cell 1Keratosis, Actinic 1Hutchinson's Melanotic Freckle 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × BF-200 ALA × Clear all
NCT02464709 2019-08-28

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Unknown
117 enrolled
Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

NCT02685592 2018-05-30

LM PDT

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
10 enrolled

Hutchinson's Melanotic Freckle

Data powered by HemOnc (CC BY 4.0) Colophon âš¡